Near‐Infrared Light‐Triggered Thermoresponsive Pyroptosis System for Synergistic Tumor Immunotherapy
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202302095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Guoqing Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Sciences and Engineering, Institute of Frontier and Interdisciplinary Science, Shandong University, Qingdao, 266237, P. R. Chi…. Hauptthemen laut MEDLINE: Nanoparticles, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Taishan Scholars Project, Shandong Natural Science Foundation.
Abstract (Originalsprache)
Pyroptosis, as an inflammatory cell death, has been widely applied in tumor therapy, but its systemic adverse reactions caused by nonspecific activation still seriously hinder its application. Herein, a near‐infrared (NIR) light‐triggered thermoresponsive pyroptosis strategy is designed for on‐demand initiation of pyroptosis and synergistic tumor immunotherapy. Specifically, glucose oxidase (GOx) loaded and heat‐sensitive material p(OEOMA‐ co ‐MEMA) (PCM) modified mesoporous Pt nanoparticles (abbreviated as PCM Pt/GOx) are prepared as the mild‐temperature triggered pyroptosis inducer. Pt nanoparticles can not only serve as nanozyme with catalase‐like activity to promote GOx catalytic reaction, but also act as photothermal agent to achieve mild‐temperature photothermal therapy (PTT) and thermoresponsive GOx release on‐demand under the irradiation of NIR light, thereby activating and promoting pyroptosis. In vitro and in vivo experiments prove that NIR light‐triggered thermoresponsive pyroptosis system exhibits excellent antitumor immunity activity as well as significantly inhibits tumor growth. The precise control of pyroptosis by NIR light as well as pyroptosis cooperated with mild‐temperature PTT for synergistically attenuated tumor immunotherapy are reported for the first time. This work provides a new method to initiate pyroptosis on demand, which is of great significance for spatiotemporally controllable pyroptosis and immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Molecular Sciences and Engineering, Institute of Frontier and Interdisciplinary Science, Shandong University, Qingdao, 266237, P. R. China.
ORCID-Profile: Chunxia Li
Förderung
- National Natural Science Foundation of China
- Taishan Scholars Project
- Shandong Natural Science Foundation
- China Postdoctoral Science Foundation
- Shandong Postdoctoral Innovation Project
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Zhu, G., Zheng, P., Wang, M., Xie, Y., Sun, Q., Gao, M., & Li, C. (2024). Near‐Infrared Light‐Triggered Thermoresponsive Pyroptosis System for Synergistic Tumor Immunotherapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202302095
Vancouver
Zhu G, Zheng P, Wang M, Xie Y, Sun Q, Gao M, et al. Near‐Infrared Light‐Triggered Thermoresponsive Pyroptosis System for Synergistic Tumor Immunotherapy. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202302095
BibTeX
@article{Zhu2024,
author = {Zhu, Guoqing and Zheng, Pan and Wang, Man and Xie, Yulin and Sun, Qianqian and Gao, Minghong and Li, Chunxia},
title = {Near‐Infrared Light‐Triggered Thermoresponsive Pyroptosis System for Synergistic Tumor Immunotherapy},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202302095}
}
EUVIMED